Lisinopril Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Lisinopril Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22519
Buy Now

Lisinopril Prices December 2023

Category Region Price
Lisinopril Pharma API USA 319,510 USD/MT
Lisinopril Pharma API Asia Pacific 289,715 USD/MT
Lisinopril Pharma API Europe 338,740 USD/MT

The price of lisinopril in the USA for Q4 2023 reached 319,510 USD/MT in December. Whereas, the price trend for lisinopril in Asia Pacific Q4 2023 reached 289,715 USD/MT in December 2023. Moreover, lisinopril prices reached 338,740 USD/MT in Europe.

Lisinopril Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Lisinopril Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of lisinopril pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of lisinopril at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of lisinopril price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing lisinopril price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Lisinopril Price Trend

Lisinopril Market Analysis

The global lisinopril market size reached US$ 226.5 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 330.8 Million, at a projected CAGR of 4.30% during 2023-2032.

  • Lisinopril market is fast growing as the fairly widespread incidence of cardiovascular diseases in people around the world. As per the estimates by the Centers for Disease Control and Prevention indicate that nearly half about 48% of American adults have a diagnosis of cardiovascular disease. In turn, medications like Lisinopril, which cells hypertension and heart failure among other conditions, are used for the management of this kind of illness. In the light of that fact that the heart disease is still the leading cause of mortality in the world today, Lisinopril has as a consequence increased both in demand and acceptance by the global health care providers since these stakeholders are currently prioritizing disease prevention and effective treatment strategies to fight the problem of the common health concern.
  • The aging demographic puts Lisinopril in front with the highest demand caused by it. For instance, the Census Bureau statistics indicate that all baby boomers will have reached 65 years and above by 2030, marking an intensity in the wave of the age-related cardiovascular diseases, which entails about 50% individual taking Lisinopril for blood pressure management. Over time, it is common for people to develop hypertension and other heart-related health problems as they age placing a high demand for pharmaceutical drugs such as Lisinopril, to keep at bay heart disease and other cardiovascular disorders among the elderly. 
  • The development of the Lisinopril market is stimulating due to the growing alarming rate of hypertension. As per the data from the National Institutes of Health, 64% of American adults have hypertension, thus pointing out how essential Lisinopril is in controlling blood pressure correctly. With the increase of the number of people adopting a stationary lifestyle and poor diets, physicians use lisinopril as a medicine to bring patients to their normal level where their blood pressure remains healthy and safe to cut down the risk of cardio-events, increase survival and improve overall health outcomes.

Lisinopril News

The report covers the latest developments, updates, and trends impacting the global lisinopril market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in lisinopril production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the lisinopril price trend.

Latest developments in the lisinopril industry:

  • August 2020: Lupin Pharmaceuticals and Sun Pharmaceuticals recalled Lisinopril and Clonazepam tablets for the US market separately. The recall of Lupin's Lisinopril, a widely used drug for hypertension treatment, was caused by the presence of a probable carcinogen in the drug at the above-acceptable levels. The recalls bring to the fore the integral quality control mechanisms of the pharmaceutical industry to ensure reliable and effective medicines for consumers. 
  • June 2020: the Unichem and Lupin announced the recall of appropriate hypertensive drugs in the American market. Unichem recalled some batches due to the presence of N-nitrosodiethylamine (NDEA), a below-acceptable limit impurity, in combination with tablets of Amlodipine and Hydrochlorothiazide. Also, Lupin has issued a recall for a specific lot of Lisinopril tablets produced to treat high blood pressure. This may have got mixed up with nitrosamine impurity named, N-nitrosodiethylamine (NDEA) in the mixture. The recalls presented also serve as an indication of the ongoing effort by the industry to promote the use of quality and safe medicines in the citizenry and the invariability of the quality control measures to safeguard public health.

Product Description

Lisinopril is a medicine that is prescribed for angiotensin-converting enzyme (ACE) inhibitors. The most common indication is the use of angiotensin receptor blockers (ARBs) for the treatment of hypertension (high blood pressure), congestive heart failure, and cardiac recovery after a myocardial infarction. Lisinopril acts by producing a non-throbbing effect in blood vessels, which consequently decreases blood pressure and facilitates better circulation of blood, relieving the burden on the heart.

Furthermore, Lisinopril is often used to treat additional health problems such as diabetic nephropathy, prevention of stroke as well as certain types of heart diseases. In such instances, it is usually co-administered with other drugs to enhance blood pressure control or to manage associated conditions.

Lisinopril is an oral medication and is taken once a day with or without food. The dosage prescribed may change depending on the patient's general condition and level of reaction to the treatment. It is crucial to stick to the dosage guidelines of the health care team and to attend frequent checkups to keep track of your blood pressure and general health.

Regional Coverage

The report provides a detailed analysis of the lisinopril market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the lisinopril price trend.

Global Lisinopril Price

The report offers a holistic view of the global lisinopril pricing trends in the form of lisinopril price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of lisinopril but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed lisinopril demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Lisinopril Price

European lisinopril prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed lisinopril price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Lisinopril Price

The analysis of lisinopril prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific lisinopril historical data within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada

Middle East and Africa Lisinopril Price

The report explores the lisinopril pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on lisinopril prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Lisinopril Price

The lisinopril pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This lisinopril price analysis can be expanded to include a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Lisinopril Price

The analysis of lisinopril prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.


This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Report Coverage

Key Attributes Details
Product Name Lisinopril
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Lisinopril Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of lisinopril pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting lisinopril price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The lisinopril price charts ensure our clients remain at the forefront of the industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Lisinopril Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More